A detailed history of Sutton Wealth Advisors Inc. transactions in Seagen Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 8 shares of SGEN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$0
Previous $1.54 Million 10.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 07, 2023

BUY
$117.37 - $139.17 $117 - $139
1 Added 14.29%
8 $1.03 Million
Q2 2022

Nov 07, 2023

BUY
$108.81 - $179.33 $761 - $1,255
7 New
7 $1.24 Million
Q1 2022

Nov 07, 2023

SELL
$119.61 - $157.85 $956 - $1,262
-8 Closed
0 $0
Q4 2021

Nov 07, 2023

BUY
$142.57 - $190.86 $1,140 - $1,526
8 New
8 $1.24 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.